# Value of Pharmacokinetic Assays in the Prediction of Therapeutic Response in Ulcerative Colitis

> **NCT03724929** · NA · TERMINATED · sponsor: **Centre Hospitalier Universitaire de Saint Etienne** · enrollment: 67 (actual)

## Conditions studied

- Ulcerative Colitis

## Interventions

- **PROCEDURE:** Blood sample
- **DEVICE:** Rectosigmoidoscopy

## Key facts

- **NCT ID:** NCT03724929
- **Lead sponsor:** Centre Hospitalier Universitaire de Saint Etienne
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-03-04
- **Primary completion:** 2022-04-15
- **Final completion:** 2022-06-28
- **Target enrollment:** 67 (ACTUAL)
- **Why stopped:** The study was stopped due to lack of inclusions
- **Last updated:** 2023-05-23

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03724929

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03724929, "Value of Pharmacokinetic Assays in the Prediction of Therapeutic Response in Ulcerative Colitis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03724929. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*